TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs1953743
log Bayes Factor = 0.026066
Chromosome 14   position 54,652,479  (GRCh37) Explore rs1953743 on Ensembl!
Variant rs1953743 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Showing all nodes without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
H65-H75 Diseases of middle ear and mastoid
0.000 0.810 0.190
H65 Nonsuppurative otitis media
0.000 0.813 0.187
H73 Other disorders of tympanic membrane
0.000 0.818 0.182
H66 Suppurative and unspecified otitis media
0.000 0.821 0.179
H65.4 Other chronic nonsuppurative otitis media
0.000 0.823 0.177
H74 Other disorders of middle ear and mastoid
0.000 0.824 0.176
H73.8 Other specified disorders of tympanic membrane
0.000 0.828 0.172
H65.9 Nonsuppurative otitis media, unspecified
0.000 0.829 0.171
H74.4 Polyp of middle ear
0.000 0.833 0.167
H70 Mastoiditis and related conditions
0.000 0.841 0.159
H73.9 Disorder of tympanic membrane, unspecified
0.000 0.843 0.157
H66.3 Other chronic suppurative otitis media
0.000 0.846 0.154
H66.4 Suppurative otitis media, unspecified
0.000 0.847 0.153
H66.2 Chronic atticoantral suppurative otitis media
0.000 0.850 0.150
H74.9 Disorder of middle ear and mastoid, unspecified
0.000 0.852 0.148
H71 Cholesteatoma of middle ear
0.000 0.853 0.147
H65.0 Acute serous otitis media
0.000 0.854 0.146
H68 Eustachian salpingitis and obstruction
0.000 0.859 0.141
H65.3 Chronic mucoid otitis media
0.000 0.861 0.139
H74.1 Adhesive middle ear disease
0.000 0.861 0.139
H69 Other disorders of Eustachian tube
0.000 0.861 0.139
H70.9 Mastoiditis, unspecified
0.000 0.863 0.137
H73.1 Chronic myringitis
0.000 0.863 0.137
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere
0.000 0.864 0.136
H67 Otitis media in diseases classified elsewhere
0.000 0.864 0.136
H74.0 Tympanosclerosis
0.000 0.866 0.134
H66.1 Chronic tubotympanic suppurative otitis media
0.000 0.869 0.131
H65.1 Other acute nonsuppurative otitis media
0.000 0.871 0.129
H66.0 Acute suppurative otitis media
0.000 0.873 0.127
H65.2 Chronic serous otitis media
0.000 0.874 0.126
H70.0 Acute mastoiditis
0.000 0.874 0.126
H66.9 Otitis media, unspecified
0.000 0.875 0.125
H73.0 Acute myringitis
0.000 0.882 0.118
H74.3 Other acquired abnormalities of ear ossicles
0.000 0.883 0.117
H74.2 Discontinuity and dislocation of ear ossicles
0.000 0.883 0.117
H70.2 Petrositis
0.000 0.886 0.114
H69.9 Eustachian tube disorder, unspecified
0.000 0.887 0.113
H70.1 Chronic mastoiditis
0.000 0.889 0.111
H68.1 Obstruction of Eustachian tube
0.000 0.894 0.106
H68.0 Eustachian salpingitis
0.000 0.899 0.101
H70.8 Other mastoiditis and related conditions
0.000 0.900 0.099
H69.0 Patulous Eustachian tube
0.000 0.900 0.099
H67.8 Otitis media in other diseases classified elsewhere
0.000 0.902 0.098
H67.1 Otitis media in viral diseases classified elsewhere
0.000 0.902 0.098
H67.0 Otitis media in bacterial diseases classified elsewhere
0.000 0.902 0.098
H75.8 Other specified disorders of middle ear and mastoid in diseases classified elsewhere
0.000 0.902 0.098
H75.0 Mastoiditis in infectious and parasitic diseases classified elsewhere
0.000 0.902 0.098
H69.8 Other specified disorders of Eustachian tube
0.000 0.916 0.084
H74.8 Other specified disorders of middle ear and mastoid
0.000 0.922 0.077
H72 Perforation of tympanic membrane
0.000 0.943 0.057
H72.1 Attic perforation of tympanic membrane
0.000 0.958 0.042
H72.0 Central perforation of tympanic membrane
0.000 0.960 0.040
H72.2 Other marginal perforations of tympanic membrane
0.000 0.965 0.034
B37 Candidiasis
0.000 0.974 0.026
B37.0 Candidal stomatitis
0.000 0.974 0.026
H72.9 Perforation of tympanic membrane, unspecified
0.000 0.975 0.025
B37.3 Candidiasis of vulva and vagina
0.000 0.975 0.025
Z80.5 Family history of malignant neoplasm of urinary tract
0.025 0.975 0.000
B37.8 Candidiasis of other sites
0.000 0.976 0.024
B37.2 Candidiasis of skin and nail
0.000 0.977 0.023
B37.9 Candidiasis, unspecified
0.000 0.979 0.021
H72.8 Other perforations of tympanic membrane
0.000 0.980 0.019
B37.1 Pulmonary candidiasis
0.000 0.980 0.019
B37.6 Candidal endocarditis
0.000 0.981 0.019
B37.5 Candidal meningitis
0.000 0.981 0.019
B37.7 Candidal septicaemia
0.000 0.981 0.018
B37.4 Candidiasis of other urogenital sites
0.000 0.982 0.018
Chapter VIII Diseases of the ear and mastoid process
0.000 0.983 0.017
Z89.5 Acquired absence of leg at or below knee
0.016 0.983 0.000
Z89.6 Acquired absence of leg above knee
0.016 0.984 0.000
Z89 Acquired absence of limb
0.016 0.984 0.000
Y43.0 Antiallergic and antiemetic drugs
0.000 0.985 0.015
Y43.4 Immunosuppressive agents
0.000 0.985 0.015
Z89.4 Acquired absence of foot and ankle
0.014 0.986 0.000
N36.8 Other specified disorders of urethra
0.000 0.986 0.014
Y43 Primarily systemic agents
0.000 0.987 0.013
Z89.2 Acquired absence of upper limb above wrist
0.012 0.987 0.000
H80-H83 Diseases of inner ear
0.000 0.988 0.012
M50.1 Cervical disk disorder with radiculopathy
0.012 0.988 0.000
Z89.8 Acquired absence of upper and lower limbs [any level]
0.012 0.988 0.000
B35-B49 Mycoses
0.000 0.988 0.012
H83 Other diseases of inner ear
0.000 0.989 0.011
Z89.3 Acquired absence of both upper limbs [any level]
0.011 0.989 0.000
Z89.1 Acquired absence of hand and wrist
0.011 0.989 0.000
Z89.9 Acquired absence of limb, unspecified
0.011 0.989 0.000
O61.0 Failed medical induction of labour
0.000 0.989 0.011
H83.0 Labyrinthitis
0.000 0.989 0.011
B44 Aspergillosis
0.000 0.990 0.010
T85.7 Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts
0.000 0.990 0.010
Y43.1 Antineoplastic antimetabolites
0.000 0.990 0.010
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.990 0.010
M50.3 Other cervical disk degeneration
0.010 0.990 0.000
M50 Cervical disk disorders
0.010 0.990 0.000
Y43.9 Primarily systemic agent, unspecified
0.000 0.990 0.010
Y43.8 Other primarily systemic agents, not elsewhere classified
0.000 0.990 0.010
Y43.6 Enzymes, not elsewhere classified
0.000 0.990 0.010
Y43.5 Acidifying and alkalising agents
0.000 0.990 0.010
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.000 0.990 0.010
H83.3 Noise effects on inner ear
0.000 0.990 0.010
Z89.7 Acquired absence of both lower limbs [any level, except toes alone]
0.010 0.990 0.000
Y42.0 Glucocorticoids and synthetic analogs
0.000 0.990 0.010
B44.1 Other pulmonary aspergillosis
0.000 0.991 0.009
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.991 0.009
H82 Vertiginous syndromes in diseases classified elsewhere
0.000 0.991 0.009
H83.9 Disease of inner ear, unspecified
0.000 0.991 0.009
B36 Other superficial mycoses
0.000 0.991 0.009
Y53 Agents primarily affecting the gastro-intestinal system
0.000 0.991 0.009
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.000 0.991 0.009
B44.9 Aspergillosis, unspecified
0.000 0.991 0.009
Y59 Other and unspecified vaccines and biological substances
0.000 0.991 0.009
Y41 Other systemic anti-infectives and antiparasitics
0.000 0.991 0.009
M50.2 Other cervical disk displacement
0.009 0.991 0.000
B48 Other mycoses, not elsewhere classified
0.000 0.991 0.008
B46 Zygomycosis
0.000 0.991 0.008
B45 Cryptococcosis
0.000 0.991 0.008
B43 Chromomycosis and phaeomycotic abscess
0.000 0.991 0.008
B42 Sporotrichosis
0.000 0.991 0.008
B41 Paracoccidioidomycosis
0.000 0.991 0.008
B40 Blastomycosis
0.000 0.991 0.008
B39 Histoplasmosis
0.000 0.991 0.008
B38 Coccidioidomycosis
0.000 0.991 0.008
Y53.1 Other antacids and anti-gastric-secretion drugs
0.000 0.991 0.009
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.000 0.991 0.008
H83.2 Labyrinthine dysfunction
0.000 0.992 0.008
H83.1 Labyrinthine fistula
0.000 0.992 0.008
H81 Disorders of vestibular function
0.000 0.992 0.008
Y46 Antiepileptics and anti-Parkinsonism drugs
0.000 0.992 0.008
Y42.9 Other and unspecified hormone antagonists
0.000 0.992 0.008
Y42.1 Thyroid hormones and substitutes
0.000 0.992 0.008
Y48 Anaesthetics and therapeutic gases
0.000 0.992 0.008
Y43.2 Antineoplastic natural products
0.000 0.992 0.008
Y52 Agents primarily affecting the cardiovascular system
0.000 0.992 0.008
K35.0 Acute appendicitis with generalised peritonitis
0.000 0.992 0.008
Y41.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.992 0.008
B47 Mycetoma
0.000 0.992 0.008
K35.9 Acute appendicitis, unspecified
0.000 0.992 0.008
B44.7 Disseminated aspergillosis
0.000 0.992 0.008
B44.2 Tonsillar aspergillosis
0.000 0.992 0.008
B44.0 Invasive pulmonary aspergillosis
0.000 0.992 0.008
Y47 Sedatives, hypnotics and antianxiety drugs
0.000 0.992 0.008
Z89.0 Acquired absence of finger(s) [including thumb], unilateral
0.008 0.992 0.000
K35 Acute appendicitis
0.000 0.992 0.008
M50.8 Other cervical disk disorders
0.008 0.992 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.000 0.992 0.007
B35 Dermatophytosis
0.000 0.992 0.008
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.992 0.007
G62.9 Polyneuropathy, unspecified
0.000 0.992 0.008
Y42.4 Oral contraceptives
0.000 0.993 0.007
Y53.2 Stimulant laxatives
0.000 0.993 0.007
Y42.2 Antithyroid drugs
0.000 0.993 0.007
Y59.0 Viral vaccines
0.000 0.993 0.007
B36.9 Superficial mycosis, unspecified
0.000 0.993 0.007
Y58 Bacterial vaccines
0.000 0.993 0.007
Y59.3 Immunoglobulin
0.000 0.993 0.007
Y42.5 Other oestrogens and progestogens
0.000 0.993 0.007
Y42.7 Androgens and anabolic congeners
0.000 0.993 0.007
Y56.3 Emollients, demulcents and protectants
0.000 0.993 0.007
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.000 0.993 0.007
Y46.5 Valproic acid
0.000 0.993 0.007
B44.8 Other forms of aspergillosis
0.000 0.993 0.007
H81.0 Meniere's disease
0.000 0.993 0.007
Y41.0 Sulphonamides
0.000 0.993 0.007
H81.9 Disorder of vestibular function, unspecified
0.000 0.993 0.007
Y41.5 Antiviral drugs
0.000 0.993 0.007
Y53.3 Saline and osmotic laxatives
0.000 0.993 0.007
B36.8 Other specified superficial mycoses
0.000 0.993 0.007
B36.3 Black piedra
0.000 0.993 0.007
B36.2 White piedra
0.000 0.993 0.007
B36.1 Tinea nigra
0.000 0.993 0.007
B36.0 Pityriasis versicolor
0.000 0.993 0.007
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.993 0.007
Y53.7 Emetics
0.000 0.993 0.007
Y53.5 Digestants
0.000 0.993 0.007
Y53.0 Histamine H2-receptor antagonists
0.000 0.993 0.007
K38 Other diseases of appendix
0.000 0.993 0.007
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.993 0.007
B96.4 Proteus (mirabilis)(morganii) as the cause of diseases classified to other chapters
0.000 0.993 0.007
H81.3 Other peripheral vertigo
0.000 0.993 0.007
Y48.3 Local anaesthetics
0.000 0.993 0.007
K35.8 Acute appendicitis, other and unspecified
0.000 0.993 0.007
K38.8 Other specified diseases of appendix
0.000 0.993 0.007
Y54.8 Agents affecting uric acid metabolism
0.000 0.993 0.007
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.993 0.007
H81.8 Other disorders of vestibular function
0.000 0.993 0.006
K38.1 Appendicular concretions
0.000 0.993 0.007
Y46.6 Other and unspecified antiepileptics
0.000 0.993 0.006
B49 Unspecified mycosis
0.000 0.993 0.006
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.993 0.006
Y41.4 Anthelminthics
0.000 0.993 0.006
Y41.3 Other antiprotozoal drugs
0.000 0.993 0.006
Y59.9 Vaccine or biological substance, unspecified
0.000 0.993 0.006
Y59.8 Other specified vaccines and biological substances
0.000 0.993 0.006
Y59.2 Protozoal vaccines
0.000 0.993 0.006
Y59.1 Rickettsial vaccines
0.000 0.993 0.006
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.993 0.006
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.993 0.006
M50.9 Cervical disk disorder, unspecified
0.006 0.994 0.000
B35.6 Tinea cruris
0.000 0.994 0.006
B38.9 Coccidioidomycosis, unspecified
0.000 0.994 0.006
B38.8 Other forms of coccidioidomycosis
0.000 0.994 0.006
B38.7 Disseminated coccidioidomycosis
0.000 0.994 0.006
B38.4 Coccidioidomycosis meningitis
0.000 0.994 0.006
B38.3 Cutaneous coccidioidomycosis
0.000 0.994 0.006
B38.2 Pulmonary coccidioidomycosis, unspecified
0.000 0.994 0.006
B38.1 Chronic pulmonary coccidioidomycosis
0.000 0.994 0.006
B38.0 Acute pulmonary coccidioidomycosis
0.000 0.994 0.006
B39.9 Histoplasmosis, unspecified
0.000 0.994 0.006
B39.5 Histoplasmosis duboisii
0.000 0.994 0.006
B39.4 Histoplasmosis capsulati, unspecified
0.000 0.994 0.006
B39.3 Disseminated histoplasmosis capsulati
0.000 0.994 0.006
B39.2 Pulmonary histoplasmosis capsulati, unspecified
0.000 0.994 0.006
B39.1 Chronic pulmonary histoplasmosis capsulati
0.000 0.994 0.006
B39.0 Acute pulmonary histoplasmosis capsulati
0.000 0.994 0.006
B40.9 Blastomycosis, unspecified
0.000 0.994 0.006
B40.8 Other forms of blastomycosis
0.000 0.994 0.006
B40.7 Disseminated blastomycosis
0.000 0.994 0.006
B40.3 Cutaneous blastomycosis
0.000 0.994 0.006
B40.2 Pulmonary blastomycosis, unspecified
0.000 0.994 0.006
B40.1 Chronic pulmonary blastomycosis
0.000 0.994 0.006
B40.0 Acute pulmonary blastomycosis
0.000 0.994 0.006
B41.9 Paracoccidioidomycosis, unspecified
0.000 0.994 0.006
B41.8 Other forms of paracoccidioidomycosis
0.000 0.994 0.006
B41.7 Disseminated paracoccidioidomycosis
0.000 0.994 0.006
B41.0 Pulmonary paracoccidioidomycosis
0.000 0.994 0.006
B42.9 Sporotrichosis, unspecified
0.000 0.994 0.006
B42.8 Other forms of sporotrichosis
0.000 0.994 0.006
B42.7 Disseminated sporotrichosis
0.000 0.994 0.006
B42.1 Lymphocutaneous sporotrichosis
0.000 0.994 0.006
B42.0 Pulmonary sporotrichosis
0.000 0.994 0.006
B43.9 Chromomycosis, unspecified
0.000 0.994 0.006
B43.8 Other forms of chromomycosis
0.000 0.994 0.006
B43.2 Subcutaneous phaeomycotic abscess and cyst
0.000 0.994 0.006
B43.1 Phaeomycotic brain abscess
0.000 0.994 0.006
B43.0 Cutaneous chromomycosis
0.000 0.994 0.006
B45.9 Cryptococcosis, unspecified
0.000 0.994 0.006
B45.8 Other forms of cryptococcosis
0.000 0.994 0.006
B45.7 Disseminated cryptococcosis
0.000 0.994 0.006
B45.3 Osseous cryptococcosis
0.000 0.994 0.006
B45.2 Cutaneous cryptococcosis
0.000 0.994 0.006
B45.1 Cerebral cryptococcosis
0.000 0.994 0.006
B45.0 Pulmonary cryptococcosis
0.000 0.994 0.006
B46.9 Zygomycosis, unspecified
0.000 0.994 0.006
B46.8 Other zygomycoses
0.000 0.994 0.006
B46.5 Mucormycosis, unspecified
0.000 0.994 0.006
B46.4 Disseminated mucormycosis
0.000 0.994 0.006
B46.3 Cutaneous mucormycosis
0.000 0.994 0.006
B46.2 Gastro-intestinal mucormycosis
0.000 0.994 0.006
B46.1 Rhinocerebral mucormycosis
0.000 0.994 0.006
B46.0 Pulmonary mucormycosis
0.000 0.994 0.006
B48.8 Other specified mycoses
0.000 0.994 0.006
B48.7 Opportunistic mycoses
0.000 0.994 0.006
B48.4 Penicillosis
0.000 0.994 0.006
B48.3 Geotrichosis
0.000 0.994 0.006
B48.2 Allescheriasis
0.000 0.994 0.006
B48.1 Rhinosporidiosis
0.000 0.994 0.006
B48.0 Lobomycosis
0.000 0.994 0.006
Y53.6 Antidiarrhoeal drugs
0.000 0.994 0.006
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.994 0.006
Y56.9 Topical agent, unspecified
0.000 0.994 0.006
Y56.8 Other topical agents
0.000 0.994 0.006
Y56.7 Dental drugs, topically applied
0.000 0.994 0.006
Y56.6 Otorhinolaryngological drugs and preparations
0.000 0.994 0.006
Y56.5 Ophthalmological drugs and preparations
0.000 0.994 0.006
Y56.2 Local astringents and local detergents
0.000 0.994 0.006
Y56.1 Antipruritics
0.000 0.994 0.006
Y48.2 Other and unspecified general anaesthetics
0.000 0.994 0.006
Y46.2 Hydantoin derivatives
0.000 0.994 0.006
Y47.1 Benzodiazepines
0.000 0.994 0.006
M50.0 Cervical disk disorder with myelopathy
0.006 0.994 0.000
Y52.7 Peripheral vasodilators
0.000 0.994 0.006
Y46.8 Antispasticity drugs
0.000 0.994 0.006
Y46.3 Deoxybarbiturates
0.000 0.994 0.006
Y46.1 Oxazolidinediones
0.000 0.994 0.006
Y46.0 Succinimides
0.000 0.994 0.006
Y52.4 Angiotensin-converting-enzyme inhibitors
0.000 0.994 0.006
Y46.4 Iminostilbenes
0.000 0.994 0.006
Y46.7 Anti-Parkinsonism drugs
0.000 0.994 0.006
Y48.5 Therapeutic gases
0.000 0.994 0.006
Y48.1 Parenteral anaesthetics
0.000 0.994 0.006
Y48.0 Inhaled anaesthetics
0.000 0.994 0.006
Y48.4 Anaesthetic, unspecified
0.000 0.994 0.006
K35.1 Acute appendicitis with peritoneal abscess
0.000 0.994 0.006
B35.4 Tinea corporis
0.000 0.994 0.006
H83.8 Other specified diseases of inner ear
0.000 0.994 0.006
Y52.8 Antivaricose drugs, including sclerosing agents
0.000 0.994 0.006
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.994 0.006
O61 Failed induction of labour
0.000 0.994 0.006
B47.1 Actinomycetoma
0.000 0.994 0.006
B47.0 Eumycetoma
0.000 0.994 0.006
K38.0 Hyperplasia of appendix
0.000 0.994 0.006
D12.8 Rectum
0.000 0.994 0.006
Y50.2 Methylxanthines, not elsewhere classified
0.000 0.994 0.006
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.994 0.006
Y41.1 Antimycobacterial drugs
0.000 0.994 0.006
H81.4 Vertigo of central origin
0.000 0.994 0.006
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.994 0.006
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.000 0.994 0.006
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.000 0.994 0.006
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.000 0.994 0.006
Y47.4 Bromine compounds
0.000 0.994 0.006
Y47.3 Paraldehyde
0.000 0.994 0.006
Y47.2 Chloral derivatives
0.000 0.994 0.006
Y47.0 Barbiturates, not elsewhere classified
0.000 0.994 0.006
N36 Other disorders of urethra
0.000 0.994 0.006
Y53.4 Other laxatives
0.000 0.994 0.006
H80 Otosclerosis
0.001 0.994 0.005
Y50.9 Central nervous system stimulant, unspecified
0.000 0.994 0.006
Y50.8 Other central nervous system stimulants
0.000 0.994 0.006
Y50.1 Opioid receptor antagonists
0.000 0.994 0.006
Y50.0 Analeptics
0.000 0.994 0.006
B35.8 Other dermatophytoses
0.000 0.994 0.006
B35.5 Tinea imbricata
0.000 0.994 0.006
B35.2 Tinea manuum
0.000 0.994 0.006
B35.0 Tinea barbae and tinea capitis
0.000 0.994 0.006
K35-K38 Diseases of appendix
0.000 0.994 0.006
Y54.5 Other diuretics
0.000 0.994 0.006
Y51 Drugs primarily affecting the autonomic nervous system
0.000 0.994 0.005
Y58.0 BCG vaccine
0.000 0.994 0.005
Y58.9 Other and unspecified bacterial vaccines
0.000 0.994 0.005
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.000 0.994 0.005
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.000 0.994 0.005
Y58.5 Diphtheria vaccine
0.000 0.994 0.005
Y58.4 Tetanus vaccine
0.000 0.994 0.005
Y58.3 Plague vaccine
0.000 0.994 0.005
Y58.2 Cholera vaccine
0.000 0.994 0.005
Y58.1 Typhoid and paratyphoid vaccine
0.000 0.994 0.005
Y44 Agents primarily affecting blood constituents
0.000 0.994 0.005
H60-H62 Diseases of external ear
0.000 0.994 0.006
K35.2 Acute appendicitis with generalized peritonitis
0.000 0.994 0.005
B47.9 Mycetoma, unspecified
0.000 0.995 0.005
B35.1 Tinea unguium
0.000 0.995 0.005
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.000 0.995 0.005
H81.2 Vestibular neuronitis
0.000 0.995 0.005
Y54.9 Mineral salts, not elsewhere classified
0.000 0.995 0.005
Y54.6 Electrolytic, caloric and water-balance agents
0.000 0.995 0.005
Y54.2 Carbonic-anhydrase inhibitors
0.000 0.995 0.005
B35.9 Dermatophytosis, unspecified
0.000 0.995 0.005
K38.3 Fistula of appendix
0.000 0.995 0.005
K38.2 Diverticulum of appendix
0.000 0.995 0.005
L05.0 Pilonidal cyst with abscess
0.005 0.995 0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.995 0.005
N36.0 Urethral fistula
0.000 0.995 0.005
O61.9 Failed induction of labour, unspecified
0.000 0.995 0.005
Y55.6 Antiasthmatics, not elsewhere classified
0.000 0.995 0.005
Y52.1 Calcium-channel blockers
0.000 0.995 0.005
Y49 Psychotropic drugs, not elsewhere classified
0.000 0.995 0.005
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.995 0.005
Y55.5 Anticommon cold drugs
0.000 0.995 0.005
Y55.3 Antitussives
0.000 0.995 0.005
Y55.2 Other and unspecified agents primarily acting on muscles
0.000 0.995 0.005
Y55.0 Oxytocic drugs
0.000 0.995 0.005
N36.9 Urethral disorder, unspecified
0.000 0.995 0.005
Y54.4 Loop [high-ceiling] diuretics
0.000 0.995 0.005
O61.1 Failed instrumental induction of labour
0.000 0.995 0.005
Y40 Systemic antibiotics
0.000 0.995 0.005
Y55.4 Expectorants
0.000 0.995 0.005
Y54.7 Agents affecting calcification
0.000 0.995 0.005
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.995 0.005
Y54.0 Mineralocorticoids
0.000 0.995 0.004
N36.2 Urethral caruncle
0.000 0.995 0.005
O61.8 Other failed induction of labour
0.000 0.995 0.004
Y40.8 Other systemic antibiotics
0.000 0.995 0.005
K38.9 Disease of appendix, unspecified
0.000 0.995 0.004
K46.9 Unspecified abdominal hernia without obstruction or gangrene
0.005 0.995 0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.995 0.004
Y44.6 Natural blood and blood products
0.000 0.995 0.004
H80.2 Cochlear otosclerosis
0.001 0.996 0.004
H80.1 Otosclerosis involving oval window, obliterative
0.001 0.996 0.004
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.000 0.996 0.004
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.000 0.996 0.004
E16.2 Hypoglycaemia, unspecified
0.004 0.996 0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.000 0.996 0.004
Y54.3 Benzothiadiazine derivatives
0.000 0.996 0.004
H80.0 Otosclerosis involving oval window, nonobliterative
0.001 0.996 0.004
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.996 0.004
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.996 0.004
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.996 0.004
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.996 0.004
Y51.1 Other parasympathomimetics [cholinergics]
0.000 0.996 0.004
Y51.0 Anticholinesterase agents
0.000 0.996 0.004
N30.2 Other chronic cystitis
0.000 0.996 0.004
Y44.9 Other and unspecified agents affecting blood constituents
0.000 0.996 0.004
Y44.7 Plasma substitutes
0.000 0.996 0.004
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.000 0.996 0.004
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.996 0.004
K63.3 Ulcer of intestine
0.004 0.996 0.000
Y40.4 Tetracyclines
0.000 0.996 0.004
H80.8 Other otosclerosis
0.001 0.996 0.003
S80.9 Superficial injury of lower leg, unspecified
0.004 0.996 0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.000 0.996 0.004
Z80.7 Family history of malignant neoplasms of lymphoid, haematopoietic and related tissues
0.004 0.996 0.000
H62 Disorders of external ear in diseases classified elsewhere
0.000 0.996 0.004
K35.3 Acute appendicitis with localized peritonitis
0.000 0.996 0.004
Q18.0 Sinus, fistula and cyst of branchial cleft
0.000 0.996 0.004
Y49.9 Psychotropic drug, unspecified
0.000 0.996 0.004
Y49.8 Other psychotropic drugs, not elsewhere classified
0.000 0.996 0.004
Y49.7 Psychostimulants with abuse potential
0.000 0.996 0.004
Y49.6 Psychodysleptics [hallucinogens]
0.000 0.996 0.004
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.996 0.004
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.000 0.996 0.004
R52.9 Pain, unspecified
0.004 0.996 0.000
Y40.5 Aminoglycosides
0.000 0.996 0.004
Y40.3 Macrolides
0.000 0.996 0.004
R52.1 Chronic intractable pain
0.004 0.996 0.000
K36 Other appendicitis
0.000 0.996 0.004
Y57 Other and unspecified drugs and medicaments
0.000 0.996 0.004
Y40.2 Chloramphenicol group
0.000 0.996 0.004
Y44.2 Anticoagulants
0.000 0.996 0.004
B35.3 Tinea pedis
0.000 0.996 0.004
Y40.7 Antifungal antibiotics, systemically used
0.000 0.996 0.004
Y49.0 Tricyclic and tetracyclic antidepressants
0.000 0.996 0.003
E10.4 With neurological complications
0.004 0.996 0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.996 0.003
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.996 0.003
Y49.2 Other and unspecified antidepressants
0.000 0.996 0.003
N36.3 Prolapsed urethral mucosa
0.000 0.996 0.003
N36.1 Urethral diverticulum
0.000 0.997 0.003
H81.1 Benign paroxysmal vertigo
0.000 0.997 0.003
E04.9 Non-toxic goitre, unspecified
0.003 0.997 0.000
Y40.6 Rifamycins
0.000 0.997 0.003
Y49.5 Other antipsychotics and neuroleptics
0.000 0.997 0.003
Z51.4 Preparatory care for treatment, not elsewhere classified
0.000 0.997 0.003
E10.8 With unspecified complications
0.003 0.997 0.000
H62.8 Other disorders of external ear in diseases classified elsewhere
0.000 0.997 0.003
H62.4 Otitis externa in other diseases classified elsewhere
0.000 0.997 0.003
H62.3 Otitis externa in other infectious and parasitic diseases classified elsewhere
0.000 0.997 0.003
H62.2 Otitis externa in mycoses
0.000 0.997 0.003
H62.1 Otitis externa in viral diseases classified elsewhere
0.000 0.997 0.003
Y52.3 Coronary vasodilators, not elsewhere classified
0.000 0.997 0.003
Y40.1 Cefalosporins and other -lactam antibiotics
0.000 0.997 0.003
Z80 Family history of malignant neoplasm
0.003 0.997 0.000
Y44.5 Thrombolytic drugs
0.000 0.997 0.003
H60 Otitis externa
0.000 0.997 0.003
Y43.3 Other antineoplastic drugs
0.000 0.997 0.003
E10 Insulin-dependent diabetes mellitus
0.003 0.997 0.000
K37 Unspecified appendicitis
0.000 0.997 0.003
H62.0 Otitis externa in bacterial diseases classified elsewhere
0.000 0.997 0.003
Z80.9 Family history of malignant neoplasm, unspecified
0.003 0.997 0.000
E10.0 With coma
0.003 0.997 0.000
H90-H95 Other disorders of ear
0.000 0.997 0.003
H60.0 Abscess of external ear
0.000 0.997 0.003
Y57.7 Vitamins, not elsewhere classified
0.000 0.997 0.003
Y57.6 Other diagnostic agents
0.000 0.997 0.003
Y57.4 Pharmaceutical excipients
0.000 0.997 0.003
Y57.3 Alcohol deterrents
0.000 0.997 0.003
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.000 0.997 0.003
Y57.1 Lipotropic drugs
0.000 0.997 0.003
Y57.0 Appetite depressants [anorectics]
0.000 0.997 0.003
N02.9 Unspecified
0.003 0.997 0.000
Z00.5 Examination of potential donor of organ and tissue
0.000 0.997 0.003
E10.2 With renal complications
0.003 0.997 0.000
N81.2 Incomplete uterovaginal prolapse
0.003 0.997 0.000
Y57.8 Other drugs and medicaments
0.000 0.997 0.003
Z71.2 Person consulting for explanation of investigation findings
0.000 0.997 0.003
H60.8 Other otitis externa
0.000 0.997 0.003
K46 Unspecified abdominal hernia
0.003 0.997 0.000
B95.1 Streptococcus, group B, as the cause of diseases classified to other chapters
0.003 0.997 0.000
H95 Postprocedural disorders of ear and mastoid process, not elsewhere classified
0.000 0.997 0.003
L05 Pilonidal cyst
0.003 0.997 0.000
H95.1 Other disorders following mastoidectomy
0.000 0.997 0.003
Q18 Other congenital malformations of face and neck
0.000 0.997 0.003
S81.8 Open wound of other parts of lower leg
0.000 0.997 0.003
K46.0 Unspecified abdominal hernia with obstruction, without gangrene
0.003 0.997 0.000
Q18.1 Preauricular sinus and cyst
0.000 0.997 0.003
R25.8 Other and unspecified abnormal involuntary movements
0.000 0.997 0.003
D63.8 Anaemia in other chronic diseases classified elsewhere
0.003 0.997 0.000
H80.9 Otosclerosis, unspecified
0.002 0.997 0.001
C07 Malignant neoplasm of parotid gland
0.003 0.997 0.000
Z80.6 Family history of leukaemia
0.003 0.997 0.000
E10.6 With other specified complications
0.003 0.997 0.000
E10.1 With ketoacidosis
0.003 0.997 0.000
S01.3 Open wound of ear
0.000 0.997 0.003
E16 Other disorders of pancreatic internal secretion
0.002 0.998 0.000
L05.9 Pilonidal cyst without abscess
0.002 0.998 0.000
C77.3 Axillary and upper limb lymph nodes
0.000 0.998 0.002
F32.1 Moderate depressive episode
0.000 0.998 0.002
S01.9 Open wound of head, part unspecified
0.000 0.998 0.002
E10.5 With peripheral circulatory complications
0.002 0.998 0.000
H94 Other disorders of ear in diseases classified elsewhere
0.000 0.998 0.002
R52 Pain, not elsewhere classified
0.002 0.998 0.000
H60.5 Acute otitis externa, non-infective
0.000 0.998 0.002
S01.7 Multiple open wounds of head
0.000 0.998 0.002
H60.3 Other infective otitis externa
0.000 0.998 0.002
H95.9 Postprocedural disorder of ear and mastoid process, unspecified
0.000 0.998 0.002
E10.7 With multiple complications
0.002 0.998 0.000
H60.4 Cholesteatoma of external ear
0.000 0.998 0.002
K40.3 Unilateral or unspecified inguinal hernia, with obstruction, without gangrene
0.002 0.998 0.000
K43.0 Ventral hernia with obstruction, without gangrene
0.000 0.998 0.002
Z82.3 Family history of stroke
0.000 0.998 0.002
H60.2 Malignant otitis externa
0.000 0.998 0.002
K46.1 Unspecified abdominal hernia with gangrene
0.002 0.998 0.000
Z80.2 Family history of malignant neoplasm of other respiratory and intrathoracic organs
0.002 0.998 0.000
S92.20 Fracture of other tarsal bone(s) (closed)
0.002 0.998 0.000
Q18.9 Congenital malformation of face and neck, unspecified
0.000 0.998 0.002
Q18.8 Other specified congenital malformations of face and neck
0.000 0.998 0.002
Q18.7 Microcheilia
0.000 0.998 0.002
Q18.6 Macrocheilia
0.000 0.998 0.002
Q18.5 Microstomia
0.000 0.998 0.002
Q18.4 Macrostomia
0.000 0.998 0.002
Q18.3 Webbing of neck
0.000 0.998 0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2026 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.